nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Prednisone—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Dexmethylphenidate—Breast disorder—Methotrexate—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Dexmethylphenidate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Insomnia—Lisinopril—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Dexmethylphenidate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Lisinopril—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Vomiting—Captopril—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Lisinopril—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Dexmethylphenidate—Rash—Captopril—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Dexmethylphenidate—Dermatitis—Captopril—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Dexmethylphenidate—Somnolence—Lisinopril—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Dexmethylphenidate—Headache—Captopril—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Dexmethylphenidate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Lisinopril—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Dexmethylphenidate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Dexmethylphenidate—Asthma—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Dexmethylphenidate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Lisinopril—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Fatigue—Lisinopril—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Dexmethylphenidate—Shock—Mycophenolate mofetil—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Methotrexate—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Constipation—Lisinopril—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Pain—Lisinopril—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Bradycardia—Prednisone—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Azathioprine—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Prednisone—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Dexmethylphenidate—Nausea—Captopril—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Prednisone—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Asthenia—Leflunomide—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Hallucination—Prednisone—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Lisinopril—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Pruritus—Leflunomide—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Dexmethylphenidate—Dizziness—Azathioprine—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Dexmethylphenidate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Leflunomide—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Dexmethylphenidate—Urticaria—Lisinopril—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Dexmethylphenidate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Lisinopril—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Lisinopril—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Dexmethylphenidate—Vomiting—Azathioprine—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Dexmethylphenidate—Pneumonia—Methotrexate—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Dexmethylphenidate—Eye disorder—Prednisone—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Dexmethylphenidate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Dexmethylphenidate—Drowsiness—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Dexmethylphenidate—Infestation—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Dexmethylphenidate—Rash—Azathioprine—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Dexmethylphenidate—Dermatitis—Azathioprine—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Depression—Methotrexate—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Flushing—Prednisone—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Headache—Azathioprine—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Dizziness—Leflunomide—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Angiopathy—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Prednisone—systemic scleroderma	0.000403	0.000403	CcSEcCtD
Dexmethylphenidate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Dexmethylphenidate—Pain—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Dexmethylphenidate—Sweating—Methotrexate—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Haematuria—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Dexmethylphenidate—Vomiting—Leflunomide—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Dexmethylphenidate—Alopecia—Prednisone—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Dexmethylphenidate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Epistaxis—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Rash—Leflunomide—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Dermatitis—Leflunomide—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Mental disorder—Prednisone—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Nausea—Azathioprine—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Headache—Leflunomide—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Dexmethylphenidate—Erythema—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Dexmethylphenidate—Malnutrition—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Dexmethylphenidate—Asthenia—Lisinopril—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Dexmethylphenidate—Pruritus—Lisinopril—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Dexmethylphenidate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Dexmethylphenidate—Rash—Mycophenolic acid—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Dexmethylphenidate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Methotrexate—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Dexmethylphenidate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Dexmethylphenidate—Headache—Mycophenolic acid—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Dexmethylphenidate—Nausea—Leflunomide—systemic scleroderma	0.000369	0.000369	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Dexmethylphenidate—Vision blurred—Prednisone—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Methotrexate—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Lisinopril—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Dexmethylphenidate—Visual impairment—Methotrexate—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Dexmethylphenidate—Anaemia—Prednisone—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Dexmethylphenidate—Agitation—Prednisone—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Dexmethylphenidate—Angioedema—Prednisone—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Dexmethylphenidate—Dizziness—Lisinopril—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Dexmethylphenidate—Nausea—Mycophenolic acid—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Dexmethylphenidate—Malaise—Prednisone—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Dexmethylphenidate—Vertigo—Prednisone—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Dexmethylphenidate—Eye disorder—Methotrexate—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Dexmethylphenidate—Syncope—Prednisone—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Prednisone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Dexmethylphenidate—Vomiting—Lisinopril—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Angiopathy—Methotrexate—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Rash—Lisinopril—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Convulsion—Prednisone—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Dermatitis—Lisinopril—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Dexmethylphenidate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Dexmethylphenidate—Hypertension—Prednisone—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Chills—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Headache—Lisinopril—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Dexmethylphenidate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Myalgia—Prednisone—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Arthralgia—Prednisone—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Anxiety—Prednisone—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Dexmethylphenidate—Alopecia—Methotrexate—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Dexmethylphenidate—Discomfort—Prednisone—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Mental disorder—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Erythema—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Dexmethylphenidate—Malnutrition—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Dexmethylphenidate—Nausea—Lisinopril—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Oedema—Prednisone—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Infection—Prednisone—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Dexmethylphenidate—Back pain—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Dexmethylphenidate—Shock—Prednisone—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Prednisone—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Dexmethylphenidate—Tachycardia—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Dexmethylphenidate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Dexmethylphenidate—Skin disorder—Prednisone—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Dexmethylphenidate—Vision blurred—Methotrexate—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Dexmethylphenidate—Anorexia—Prednisone—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Dexmethylphenidate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Dexmethylphenidate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Dexmethylphenidate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Dexmethylphenidate—Insomnia—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Prednisone—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Prednisone—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Dexmethylphenidate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Prednisone—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Dexmethylphenidate—Fatigue—Prednisone—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Dexmethylphenidate—Constipation—Prednisone—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Prednisone—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—systemic scleroderma	0.000253	0.000253	CcSEcCtD
Dexmethylphenidate—Urticaria—Prednisone—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Prednisone—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Prednisone—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Prednisone—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—systemic scleroderma	0.00023	0.00023	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Dexmethylphenidate—Asthenia—Prednisone—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Dexmethylphenidate—Pruritus—Prednisone—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Prednisone—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—systemic scleroderma	0.000211	0.000211	CcSEcCtD
Dexmethylphenidate—Dizziness—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Dexmethylphenidate—Vomiting—Prednisone—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Dexmethylphenidate—Rash—Prednisone—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Dexmethylphenidate—Dermatitis—Prednisone—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Dexmethylphenidate—Headache—Prednisone—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Dexmethylphenidate—Asthenia—Methotrexate—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Dexmethylphenidate—Nausea—Prednisone—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—systemic scleroderma	0.000187	0.000187	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—systemic scleroderma	0.000166	0.000166	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
